Drug Discovery Outsourcing Global Market-Forecast to 2025

Publishing Date : September, 2017
Report Code : HCPH0106
Price:
Single license $7,200
Site license $9,000
Global license $12,000


The global pharmaceutical outsourcing market was estimated to be $XX billion in 2016 and of that a little less than fifty percent accounted for CRO’s. IQ4I estimates that the global drug discovery based services to be $XX billion in 2016 and rest accounts for biology-related service and clinical services. Current R&D outsourcing penetration is estimated to be ~ X percent of the global pharmaceutical and biotech industry spending but poised to grow at CAGR of X% percent in the coming years.

This report provides comprehensive insights on the global drug discovery outsourcing market. The report covers all segments, global trends and emerging strategies of the outsourcing market related to drug discovery. Major Drug Discovery Outsourcing (DDO) players included in the report are Advinus, AMRI, Aurigene, BioDuro, Charles River Laboratories (CRL), Chem Partner, Evotec, GVK Biosciences, Jubilant, Pharmaron, Shanghai Medicilon, Sundia Meditech, Syngene, TCG Lifesciences and Wuxi Apptec.

This report caters to the need of Contract research organizations, Pharmaceutical/Biotech companies, Academic institutes, Individual researchers, Investors, Service providers and other associated stake holders to identify and analyze the potential of the DDO market. The report also provides insights on customer base, number of deals between CRO’s and Pharmaceutical /biotech firms, global FTE rates, employee strength & number of companies, revenue per employee of major players, therapeutic area gap analysis and successful research collaboration outcomes of selected CRO’s and Sponsors, which are likely to have an impact on the DDO market in the foreseeable future.

This report covers in-depth analysis of major players by therapeutic area of focus, capabilities, geographic presence, business models, financials, collaborations, acquisitions, various marketing strategies adopted along with insightful analysis on conferences, clusters and match making websites.

  • 1     INTRODUCTION
  • 2     MARKET ANALYSIS
    • 2.1     RESEARCH METHODOLOGY
    • 2.2     FORECASTING MODEL
    • 2.3     MARKET DYNAMICS
    • 2.4     MARKET SIZING
    • 2.5     EMERGING TRENDS & STRATEGIES
  • 3     BUSINESS OVERVIEW
    • 3.1     BUSINESS MODELS
    • 3.2     BUSINESS EVOLUTION
    • 3.3     CERTIFICATIONS
    • 3.4     DD INDICATORS
    • 3.5     PHARMA R&D EXP & INTENSITY
  • 4     COMPETITOR ANALYSIS
    • 4.1     THERAPEUTIC AREA MATRIX
    • 4.2     GLOBAL FTE RATES
    • 4.3     REGIONAL REVENUES VS FTE
    • 4.4     KEYPLAYERS (REVENUE PER EMPLOYEE, CUSTOMERS, DEALS & TA PIE CHART, COLLABORATION OUTCOMES)
  • 5     LEADING PLAYERS
    • 5.1     OVERVIEW
    • 5.2     CAPABILITIES
    • 5.3     THERAPEUTIC AREA
    • 5.4     BUSINESS MODELS
    • 5.5     COLLABORATIONS
    • 5.6     ACQUISITIONS
  • 6     MARKETING STRATEGIES
    • 6.1     CONFERENCES
      • 6.1.1     CONFERENCES -2015, 2016, 2017
      • 6.1.2      CONFERENCE ANALYSIS- 2016
    • 6.2     MATCH MAKING WEBSITES
    • 6.3     VIRTUAL PHARMACEUTICALS
    • 6.4     ONLINE RPFS
    • 6.5     NETWORKING WEBSITES
    • 6.6     CLUSTERS
    • 6.7     OTHER MARKETING STRATEGIES
      • 6.7.1      WEBSITE RANKINGS